New York · 2025 Regular Session · Bill
S 5580: Requires the commissioner of health to establish and publish a list of generic drug products; repealer
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 5580 is a bill introduced in the New York Senate on February 25, 2025. According to its official title, it concerns: Requires the commissioner of health to establish and publish a list of generic drug products; repealer. Primary sponsor: Andrew Lanza (Republican/Conservative/Independence/Reform). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires the commissioner of health to establish and publish a list of generic drug products.
Sponsors
Sponsors by party (alphabetical): Republican/Conservative/Independence/Reform 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Andrew Lanza | Primary sponsor | Republican/Conservative/Independence/Reform | Senate | 24 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH